| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 7 |
| 1 | CISPLATIN | 7 |
| 2 | CYCLOPHOSPHAMIDE | 7 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 5 | ETOPOSIDE | 7 |
| 6 | METHOTREXATE | 7 |
| 7 | METHOTREXATE SODIUM | 7 |
| 8 | PACLITAXEL | 7 |
| 9 | PACLITAXEL (AIBUMIN-BOUND) | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REMIMAZOLAM BESYLATE | 1 | 0.0090 |
| 1 | REVEFENACIN | 1 | 0.0011 |
| 2 | DESFLURANE | 1 | 0.0006 |
| 3 | ENSIFENTRINE | 1 | 0.0005 |
| 4 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 1 | 0.0005 |
| 5 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| 6 | BRENSOCATIB | 1 | 0.0004 |
| 7 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | DEXMEDETOMIDINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 7 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 7 |
| 2 | Microtubule Inhibitor [EPC] | 7 |
| 3 | Platinum-based Drug [EPC] | 7 |
| 4 | Topoisomerase Inhibitor [EPC] | 7 |
| 5 | Corticosteroid [EPC] | 6 |
| 6 | Osmotic Laxative [EPC] | 4 |
| 7 | BCL-2 Inhibitor [EPC] | 3 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| 9 | Azole Antifungal [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 1 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | Anticholinergic [EPC] | 1 | 0.0001 |
| 4 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 5 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 6 | General Anesthetic [EPC] | 2 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 7 | 0.0000 |